Progress and challenges in the understanding of chronic urticaria

Allergy, Asthma and Clinical Immunology

Volumn 3, Issue 1, 2007, Pages 31-35

  Ferrer, Marta ^a   Kaplan, Allen P ^b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b National Allergy   (United States)

Author keywords

Autoimmunity; Basophils; Chronic urticaria; Cotinine; IgE receptor; Mast cells

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 4; LEUKOTRIENE C4;

AUTOIMMUNITY; BASOPHIL; CELL POPULATION; CHRONIC URTICARIA; CLINICAL EVALUATION; CYTOKINE PRODUCTION; HUMAN; LABORATORY TEST; LYMPHOCYTE; MAST CELL; MOLECULAR MECHANICS; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; TH1 CELL; TH2 CELL;

EID: 34247486202     PISSN: 17101484     EISSN: None     Source Type: Journal    
DOI: 10.2310/7480.2006.00016     Document Type: Review

References (48)

1. Gaig P, Olona M, Muñoz Lejarazu D, et al. Epidemiology of urticaria in Spain. J Invest Allergol Clin Immunol 2004;14:342-5.
2. O'Donnell BF, Lawlor F, Simpson J, et al. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997;136:197-201.
3. Grob JJ, Gaudy-Marqueste C. Urticaria and quality of life. Clin Rev Allergy Immunol 2006;30:47-51.
4. Leznoff A, Josse RG, Denburg J, Dolovich J. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 1983;119:636-40.
5. Gruber BL, Baeza ML, Marchese MJ, et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988;90:213-7.
6. Hide M, Francis DM, Grattan CE, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993;328:1599-604.
7. Niimi N, Francis DM, Kermani F, et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996;106:1001-6.
8. Ferrer M, Kinet JP, Kaplan AP. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol 1998;101: 672-6.
9. Ferrer M, Nakazawa K, Kaplan AP. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 1999;104:169-72.
10. Kikuchi Y, Kaplan AP. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 2002;109:114-8.
11. Sabroe RA, Grattan CE, Francis DM, et al. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999;140:446-52.
12. Fiebiger E, Hammerschmid F, Stingl G, Maurer D. Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 1998;101:243-51.
13. Kikuchi Y, Kaplan AP. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 2001;107: 1056-62.
14. Horn MP, Gerster TF, Ochensberger BF, et al. Human antiFcepsilonRIalpha autoantibodies isolated from healthy donors cross-react with tetanus toxoid. Eur J Immunol 1999;29:1139-48.
15. Pachlopnik JM, Horn MP, Fux M, et al. Natural antiFc[epsiv]RI[alpha] autoantibodies may interfere with diagnostic tests for autoimmune urticaria. J Autoimmun 2004;22:43-51.
16. Horn MP, Pachlopnik JM, Vogel M, et al. Conditional autoimmunity mediated by human natural anti-FceRIa autoantibodies? FASEB J 2001;15:2268-74.
17. Sabroe RA, Fiebiger E, Francis DM, et al. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002;110:492-9.
18. Ferrer M, Luquin E, Kaplan AP. IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera. Allergy 2003; 58:802-7.
19. Puccetti A, Bason C, Simeoni S, et al. In chronic idiopathic urticaria autoantibodies against FceRII/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy 2005;35:1599-607.
20. O'Donnell BF, O'Neill CM, Francis DM, et al. Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 1999;140:853-8.
21. Ferrer M, Luquin E, Sanchez-Ibarrola A, et al. Secretion of cytokines, histamine and leukotrienes in chronic urticaria. Int Arch Allergy Immunol 2002;129:254-60.
22. Yasnowsky KM, Dreskin SC, Efaw B, et al. Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol 2006;117:1430-4
23. Stewart GE. Histopathology of chronic urticaria. Clin Rev Allergy Immunol 2002;23:195-200.
24. Natbony SF, Phillips ME, Elias JM, et al. Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol 1983;71:177-83.
25. Hermes B, Prochazka AK, Haas N, et al. Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol 1999;103:307-14.
26. Haas N, Toppe E, Henz BM. Microscopic morphology of different types of urticaria. Arch Dermatol 1998;134:41-6.
27. Ying S, Kikuchi Y, Meng Q, et al. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 2002;109: 694-700.
28. Openshaw P, Murphy EE, Hosken NA, et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 1995;182:1357-67.
29. Barlow RJ, Ross EL, MacDonald DM, et al. Mast cells and T lymphocytes in chronic urticaria. Clin Exp Allergy 1995;25:317-22.
30. Grattan CE, Sabroe RA, Greaves MW. Chronic urticaria. J Am Acad Dermatol 2002;46:645-57.
31. Grattan CE, Walpole D, Francis DM, et al. Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity. Clin Exp Allergy 1997;27:1417-24.
32. Plaut M, Kazimierczak W, Lichtenstein LM. Abnormalities of basophil "releasability" in atopic and asthmatic individuals. J Allergy Clin Immunol 1986;78:968-73.
33. Lawrence ID, Warner JA, Cohan VL, et al. Bradykinin analog induces histamine release from human skin mast cells. Adv Exp Med Biol 1989;247:225-9.
34. Alam R, Forsythe P, Stafford S, et al. Monocyte chemotactic protein-2, monocyte chemotactic protein-3, and fibroblast-induced cytokine. Three new chemokines induce chemotaxis and activation of basophils. J Immunol 1994;153:3155-9.
35. Fureder W, Agis H, Willheim M, et al. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J Immunol 1995;155:3152-60.
36. Luquin E, Kaplan AP, Ferrer M. Increased responsiveness of basophils of patients with chronic urticaria to sera but hyporesponsiveness to other stimuli. Clin Exp Allergy 2005;35:456-60.
37. Kern F, Lichtenstein LM. Defective histamine release in chronic urticaria. J Clin Invest 1976;57:1369-77.
38. Bischoff SC, Zwahlen R, Stucki M, et al. Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthma. Int Arch Allergy Immunol 1996;110:261-71.
39. Greaves MW, Plummer VM, McLaughlan P, Stanworth DR. Serum and cell bound IgE in chronic urticaria. Clin Allergy 1974;4: 265-71.
40. Wahn U, Ernsting M, Peterson J. Spontaneous histamine release from washed leukocytes and whole blood in atopic and non-atopic individuals. Allergy 1990;45:109-14.
41. Zuberbier T, Schwarz S, Hartmann K, et al. Histamine releasability of basophils and skin mast cells in chronic urticaria. Allergy 1996; 51:24-8.
42. Alam R, Lett-Brown MA, Forsythe PA, et al. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J Clin Invest 1992;89:723-8.
43. Confino-Cohen R, Aharoni D, Goldberg A, et al. Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria. J Allergy Clin Immunol 2002; 109:349-56.
44. Grattan CE, Dawn G, Gibbs S, Francis DM. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy 2003;33:337-41.
45. Sabroe RA, Poon E, Orchard GE, et al. Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Allergy Clin Immunol 1999;103:484-93.
46. Marsland AM, Soundararajan S, Joseph K, Kaplan AP. Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria. Clin Exp Allergy 2005;35:554-9.
47. O'Donnell BF, Barr RM, Black AK, et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998;138: 101-6.
48. Kessel A, Bamberger E, Toubi E. Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective study. J Am Acad Dermatol 2005;52:145-8.